# Covista Inc. (CVSA)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/covista-inc/ JSON: https://steadybase.io/company/covista-inc.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: Covista Inc.
- Ticker: CVSA (NYSE)
- SEC CIK: 0000730464
- Industry: Services-Educational Services (SIC 8200)
- Headquarters: Chicago, IL
- Fiscal year ends: June 30
- SEC filer category: Large accelerated filer
- Website: covista.com
- Investor relations: https://investors.covista.com/overview/default.aspx
- LinkedIn: https://www.linkedin.com/company/covista-official
- Next earnings date: Jan 27, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.0B for the fiscal year ended Jun 30, 2026 (10-K filed Aug 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/0001104659-26-092044-index.html
- Operating income: $383.4M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/0001104659-26-092044-index.html
- Net income: $251.6M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/0001104659-26-092044-index.html
- SG&A: $730.7M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/0001104659-26-092044-index.html
- Shares outstanding: 33,255,241 as of Oct 23, 2026 (10-Q filed Oct 29, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926120213/0001104659-26-120213-index.html
- Auditor: Pricewaterhousecoopers LLP, Chicago, Illinois, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm

## Business

Covista is America’s largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University (“Chamberlain”), Walden University (“Walden”), American University of the Caribbean School of Medicine (“AUC”), Ross University School of Medicine (“RUSM”), and Ross University School of Veterinary Medicine (“RUSVM”). Covista delivers education to its students at multiple campuses and online.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Jun 30, 2026 | $2.0B | $383.4M | $251.6M | $730.7M |
| Jun 30, 2025 | $1.8B | $341.5M | $237.1M | $672.0M |
| Jun 30, 2024 | $1.6B | $217.1M | $136.8M | $633.0M |
| Jun 30, 2023 | $1.5B | $168.2M | $93.4M | $586.0M |
| Jun 30, 2022 | $1.4B | $76.7M | $311.0M | $566.5M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/covista-inc.json

## Officers and directors

- Steve Beard, Chairman and Chief Executive Officer, Covista. Source: 8-K filed Oct 29, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000062/cvsa-ex99d1.htm
- Stephen W. Beard, Chairman & CEO. Source: Form 4 filed Aug 25, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000044/0000730464-26-000044-index.htm
- Robert J. Phelan, Chief Financial Officer. LinkedIn: https://linkedin.com/in/bob-phelan-. Source: Form 4 filed Aug 25, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000048/0000730464-26-000048-index.htm
- Amelia Manning, President, Chamberlain University. LinkedIn: https://linkedin.com/in/amelia-manning-3453919. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Karen Sue Cox, President, Chamberlain Univ.. Source: Form 4 filed May 12, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000023/0000730464-26-000023-index.htm
- Evan Trent, President, Adtalem Elevate. Source: Form 4 filed Nov 14, 2025, https://www.sec.gov/Archives/edgar/data/730464/000073046425000056/0000730464-25-000056-index.htm
- Manjunath Gangadharan, VP, Chief Accounting Officer. Source: Form 4 filed Aug 28, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000052/0000730464-26-000052-index.htm
- Megan Noel, Senior Vice President, Chief Corporate Affairs Officer. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Sara Hill, Senior Vice President, Chief Human Resources Officer. LinkedIn: https://linkedin.com/in/sara-hill. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Scott Liles, Chief Strategy and Performance Officer and President, Medical and Veterinary. LinkedIn: https://linkedin.com/in/scottliles. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Maurice Herrera, SVP - Chief Marketing Officer. Source: Form 4 filed Nov 14, 2025, https://www.sec.gov/Archives/edgar/data/730464/000073046425000045/0000730464-25-000045-index.htm
- Douglas G. Beck, SVP, GC, Corp. Sec & ISS. LinkedIn: https://linkedin.com/in/douglas-beck. Source: Form 4 filed Aug 25, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000045/0000730464-26-000045-index.htm
- Michael Betz, Pres. Walden University & CDO. LinkedIn: https://linkedin.com/in/betz-michael. Source: Form 4 filed Aug 25, 2026, https://www.sec.gov/Archives/edgar/data/730464/000073046426000051/0000730464-26-000051-index.htm
- Betty Vandenbosch, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Donna J. Hrinak, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Georgette Kiser, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Kenneth J. Phelan, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Lisa W. Wardell, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Michael W. Malafronte, Lead Independent Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- Sharon O’Keefe, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- William Krehbiel, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- William W. Burke, Director. Source: 10-K filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm

## Recent 8-K events

- Oct 29, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000062/cvsa-20261029x8k.htm
- Sep 23, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000055/cvsa-20260918x8k.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000037/cvsa-20260806x8k.htm
- Jul 28, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926087540/cvsa-20260728x8k.htm
- May 7, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000021/cvsa-20260507x8k.htm
- Apr 9, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000015/cvsa-20260409x8k.htm
- Mar 3, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000010/cvsa-20260302x8k.htm
- Feb 24, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000007/cvsa-20260224x8k.htm
- Feb 6, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000110465926011611/atge-20260205x8k.htm
- Jan 28, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000003/atge-20260128x8k.htm

## Insider trades (Form 4)

- Oct 9, 2026: Stephen W. Beard (Chairman & CEO) sold 8,306 shares, about $1.1M. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000057/0000730464-26-000057-index.htm
- Aug 27, 2026: Manjunath Gangadharan (VP, Chief Accounting Officer) sold 1,802 shares, about $247,198. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000052/0000730464-26-000052-index.htm
- Aug 11, 2026: Stephen W. Beard (Chairman & CEO) sold 3,545 shares, about $462,091. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000040/0000730464-26-000040-index.htm
- Aug 7, 2026: Robert J. Phelan (Chief Financial Officer) sold 2,186 shares, about $295,438. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000039/0000730464-26-000039-index.htm
- Aug 7, 2026: Douglas G. Beck (SVP, GC, Corp. Sec & ISS) sold 4,526 shares, about $614,676. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000038/0000730464-26-000038-index.htm
- Jul 13, 2026: Stephen W. Beard (Chairman & CEO) sold 5,291 shares, about $702,380. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000032/0000730464-26-000032-index.htm
- Jul 8, 2026: Robert J. Phelan (Chief Financial Officer) sold 5,314 shares, about $719,520. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000031/0000730464-26-000031-index.htm
- Jul 8, 2026: Douglas G. Beck (SVP, GC, Corp. Sec & ISS) sold 5,089 shares, about $688,904. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000030/0000730464-26-000030-index.htm
- Jun 11, 2026: Stephen W. Beard (Chairman & CEO) sold 5,291 shares, about $690,189. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000029/0000730464-26-000029-index.htm
- May 8, 2026: Robert J. Phelan (Chief Financial Officer) sold 10,000 shares, about $1.3M. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000025/0000730464-26-000025-index.htm
- May 8, 2026: Douglas G. Beck (SVP, GC, Corp. Sec & ISS) sold 9,615 shares, about $1.2M. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000024/0000730464-26-000024-index.htm
- May 8, 2026: Karen Sue Cox (President, Chamberlain Univ.) sold 2,000 shares, about $249,000. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000023/0000730464-26-000023-index.htm
- May 8, 2026: Stephen W. Beard (Chairman & CEO) sold 15,874 shares, about $2.1M. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000022/0000730464-26-000022-index.htm
- Mar 11, 2026: Michael W. Malafronte (Director) bought 36,036 shares, about $3.6M. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000012/0000730464-26-000012-index.htm
- Mar 3, 2026: Michael W. Malafronte (Director) bought 1,200 shares, about $117,564. Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000011/0000730464-26-000011-index.htm

## What management said

- "Purpose at Scale is delivering and all four pillars of the strategy are contributing to our momentum. Total enrollment grew for the 13th consecutive quarter, powering our double-digit revenue growth and continued margin expansion. On that strength, we are raising our fiscal 2027 guidance" Steve Beard, Chairman and Chief Executive Officer, Covista (8-K filed Oct 29, 2026). Source: https://www.sec.gov/Archives/edgar/data/730464/000073046426000062/cvsa-ex99d1.htm

## Latest filings

- 8-K filed Oct 29, 2026: https://www.sec.gov/Archives/edgar/data/730464/000073046426000062/cvsa-20261029x8k.htm
- 10-K filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/730464/000110465926092044/cvsa-20260630x10k.htm
- 10-Q filed Oct 29, 2026: https://www.sec.gov/Archives/edgar/data/730464/000110465926120213/cvsa-20260930x10q.htm
- DEF 14A filed Oct 2, 2026: https://www.sec.gov/Archives/edgar/data/730464/000110465926113316/cvsa-20261111xdef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/